Brief: Tetra Bio-Pharma Resumes Phase 3 Clinical Trial Program In Advanced Cancer Pain Patients

Tetra Bio Pharma

09/04/2019 12:49

April 9 (Reuters) - Tetra Bio Pharma Inc  TBP.V :
    * TETRA BIO-PHARMA RESUMES ITS PHASE 3 CLINICAL TRIAL
PROGRAM
    * TETRA BIO PHARMA INC - HAS DECIDED TO BRAND ITS
INVESTIGATIONAL
DRUG NAME FOR REGULATORY FILING PURPOSES
    * TETRA BIO - TO RESUME ITS PHASE 3 CLINICAL PROGRAM IN
ADVANCED
CANCER PAIN PATIENTS WITH OBJECTIVE TO ASSESS HEALTH- RELATED
QUALITY OF LIFE
    * TETRA BIO PHARMA INC - NEW DRUG FORMERLY REFERRED TO AS
PPP-001
WILL BE INVESTIGATED IN SERENITY © STUDY UNDER COMMERCIAL
TRADEMARK OF CAUMZ

Source text for Eikon:  ID:nGNX5JHSKZ 
Further company coverage:  TBP.V 

 ((Reuters.Briefs@thomsonreuters.com;))